Brainard Diana bought NKTR
September 30, 2025 · Form 4 insider transaction
Brainard Diana bought 8,000 shares of Nektar Therapeutics at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
8,000
Price
$0.00
Total value
N/A
InsiderBrainard Diana
RoleDirector
CompanyNektar Therapeutics (NKTR)
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateSeptember 30, 2025
Filing dateOctober 1, 2025
Shares owned after8,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This stock option vests in substantially equal monthly installments over the one-year period beginning on September 30, 2025.